Optune® device

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaNCT06556563NovoCure GmbHPhase 3Active not recruiting2029-04Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.